Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

PerkinElmer Buys Technology from Agilix

Facebook Twitter LinkedIn Email Comments
WELLESLEY, Mass., March 10, 2006 -- Global technology company PerkinElmer Inc. announced it has acquired Agilix Corp.'s proprietary proteomics technology, a mass spectrometry-based approach used to determine changes in levels of proteins with a high degree of precision and without the use of analyte-specific reagents. Terms of the deal were not disclosed.

"PerkinElmer will use the intellectual property acquired from Agilix to develop a number of new technologies that will bring quantitative proteomics to a wider range of customers in drug discovery," said Robert F. Friel, president, PerkinElmer Life and Analytical Sciences. PerkinElmer also manufactures products and systems within two other business units, optoelectronics and fluid sciences.

Agilix, based in Woodbridge, Conn., has developed a labeling technology using isobaric mass tags that allows for the simultaneous quantification of molecules, such as proteins, from multiple samples. PerkinElmer says the technology enhances the utility of mass spectrometry, a preferred method for proteomic analysis.

For more information, visit:
Mar 2006
mass spectrometry
An instrumental technique that utilizes the mass-to-charge ratio of charged particles as recorded from a mass spectrometer in order to determine the mass of a particle as well as the chemical makeup, or elemental ionic composition of a given sample or molecule.
Agilixanalysisdrugmass spectrometryNews & FeaturesPerkinElmerproteomicsspectroscopy

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.